Platform Overview
Trial Scanner is an AI-assisted clinical trial recruitment platform that improves the efficiency of digital patient outreach through advanced audience modeling and optimized advertising delivery.
The system analyzes publicly available digital engagement patterns to identify audience segments where information about a specific clinical trial is likely to be relevant.
This analysis is based on observable online behavior signals available through standard advertising platforms. It does not involve access to medical records, private health communities, or protected health information.
Recruitment campaigns are delivered through standard digital advertising platforms such as social media networks and search engines.
Trial Scanner does not operate outside of conventional advertising channels and does not access restricted communities or patient registries. Campaign materials are designed to support IRB review prior to deployment, consistent with applicable regulatory guidance.
Individuals encounter recruitment messages within their normal online environments and may choose whether to learn more.
There is no obligation to respond. Those who wish to learn more are directed to a landing page or intake form where they can review information about the study and decide whether to proceed. Trial Scanner does not contact individuals directly beyond the initial advertising impression.
Those who express interest are directed to a structured pre-qualification process designed to determine whether they may be appropriate candidates for a particular study.
This process typically involves a series of questions based on the study's eligibility criteria. Individuals who complete the intake process are not enrolled in a study. Clinical enrollment decisions remain with the investigative site and are subject to the full informed consent process.
Qualified candidate information is transferred to the clinical site or sponsor according to the applicable data handling framework.
This transfer is conducted in a manner consistent with HIPAA requirements and the data use agreements in place for the study. Trial Scanner's role concludes at the point of referral. Subsequent contact, screening, and enrollment are conducted by the sponsor or investigative site under their own protocols.
Design Principles
Trial Scanner does not access medical records, private patient data, or restricted communities at any stage of the recruitment process.
Audience modeling is based exclusively on publicly available digital engagement patterns accessible through standard advertising platforms.
Participation in the recruitment process is entirely voluntary and begins only when an individual responds to a recruitment message.
Compliance by Design
Every stage of the Trial Scanner pipeline is designed to align with FDA recruitment advertising guidance, IRB oversight requirements, HIPAA privacy protections, and FTC advertising standards. The platform does not access medical records or protected health information and does not monitor private patient communities.
Read the compliance frameworkSchedule a demonstration to see how Trial Scanner can be applied to your therapeutic area and enrollment goals.
Request a Demo